|
1
|
Ishikawa K, He S, Terasaki H, Nazari H,
Zhang H, Spee C, Kannan R and Hinton DR: Resveratrol inhibits
epithelial mesenchymal transition of retinal pigment epithelium and
development of proliferative vitreoretinopathy. Sci Rep.
5:163862015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ryan SJ: The pathophysiology of
proliferative vitreoretinopathy in its management. Am J Ophthalmol.
100:188–193. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Newsome DA, Rodrigues MM and Machemer R:
Human massive periretinal proliferation. In vitro characteristics
of cellular components. Arch Ophthalmol. 99:873–880. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ricker LJ, Kessels AG, de Jager W,
Hendrikse F, Kijlstra A and La Heij EC: Prediction of proliferative
vitreoretinopathy after retinal detachment surgery: Potential of
biomarker profiling. Am J Ophthalmol. 154:347–354.e2. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ricker LJ, Altara R, Goezinne F, Hendrikse
F, Kijlstra A and La Heij EC: Soluble apoptotic factors and
adhesion molecules in rhegmatogenous retinal detachment. Invest
Ophthalmol Vis Sci. 52:4256–4262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ricker LJ, Kijlstra A, de Jager W, Liem
AT, Hendrikse F and La Heij EC: Chemokine levels in subretinal
fluid obtained during scleral buckling surgery after rhegmatogenous
retinal detachment. Invest Ophthalmol Vis Sci. 51:4143–4150. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bromberg-White JL, Glazer L, Downer R,
Furge K, Boguslawski E and Duesbery NS: Identification of
VEGF-independent cytokines in proliferative diabetic retinopathy
vitreous. Invest Ophthalmol Vis Sci. 54:6472–6480. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoerster R, Hermann MM, Rosentreter A,
Muether PS, Kirchhof B and Fauser S: Profibrotic cytokines in
aqueous humour correlate with aqueous flare in patients with
rhegmatogenous retinal detachment. Br J Ophthalmol. 97:450–453.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ricker LJ, Kijlstra A, Kessels AG, de
Jager W, Liem AT, Hendrikse F and La Heij EC: Interleukin and
growth factor levels in subretinal fluid in rhegmatogenous retinal
detachment: A case-control study. PLoS One. 6:e191412011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Symeonidis C, Papakonstantinou E, Androudi
S, Georgalas I, Rotsos T, Karakiulakis G, Diza E and Dimitrakos SA:
Comparison of interleukin-6 and matrix metalloproteinase expression
in the subretinal fluid and the vitreous during proliferative
vitreoretinopathy: Correlations with extent, duration of RRD and
PVR grade. Cytokine. 67:71–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
David J: Delayed hypersensitivity in
vitro: Its mediation by cell-free substances formed by lymphoid
cell-antigen interaction. Proc Natl Acad Sci USA. 56:72–77. 1966.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bloom B and Bennet B: Mechanism of a
reaction in vitro associated with delayed-type hypersensitivity.
Science. 153:80–82. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nishihira J, Koyama Y and Mizue Y:
Identification of macrophage migration inhibitory factor (MIF) in
human vascular endothelial cells and its induction by
lipopolysaccharide. Cytokine. 10:199–205. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abe R, Shimizu T, Ohkawara A and Nishihira
J: Enhancement of macrophage migration inhibitory factor (MIF)
expression in injured epidermis and cultured fibroblasts.
Biochimica Biophysica Acta. 1500:1–9. 2000. View Article : Google Scholar
|
|
15
|
Onodera S, Suzuki K, Matsuno T, Kaneda K,
Kuriyama T and Nishihira J: Identification of macrophage migration
inhibitory factor in murine neonatal calvariae and osteoblasts.
Immunology. 89:430–435. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernhagen J, Calandra T, Mitchell RA,
Martin SB, Voelter W, Manogue KR, Cerami A and Bucala R: MIF is a
pituitary-derived cytokine that potentiates lethal endotoxaemia.
Nature. 365:756–759. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barnes MA, McMullen MR, Roychowdhury S,
Madhun NZ, Niese K, Olman MA, Stavitsky AB, Bucala R and Nagy LE:
Macrophage migration inhibitory factor is required for recruitment
of scar-associated macrophages during liver fibrosis. J Leukoc
Biol. 97:161–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olivieri C, Bargagli E, Inghilleri S,
Campo I, Cintorino M and Rottoli P: Macrophage migration inhibitory
factor in lung tissue of idiopathic pulmonary fibrosis patients.
Exp Lung Res. 42:263–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimizu T, Nishihira J, Watanabe H, Abe R,
Honda A, Ishibashi T and Shimizu H: Macrophage migration inhibitory
factor is induced by thrombin and factor Xa in endothelial cells. J
Biol Chem. 279:13729–12737. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsuda A, Tagawa Y, Matsuda H and
Nishihira J: Identification and immunohistochemical localization of
macrophage migration inhibitory factor in human cornea. FEBS Lett.
385:225–228. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuda A, Tagawa Y, Yoshida K, Matsuda H
and Nishihira J: Expression of macrophage migration inhibitory
factor in rat retina and its immunohistochemical localization. J
Neuroimmunol. 77:85–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mitamura Y, Takeuchi S, Matsuda A, Tagawa
Y, Mizue Y and Nishihira J: Macrophage migration inhibitory factor
levels in the vitreous of patients with proliferative
vitreoretinopathy. Am J Ophthalmol. 128:763–765. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Veillat V, Carli C, Metz CN, Al-Abed Y,
Naccache PH and Akoum A: Macrophage migration inhibitory factor
elicits an angiogenic phenotype in human ectopic endometrial cells
and triggers the production of major angiogenic factors via CD44,
CD74, and MAPK signaling pathways. J Clin Endocrinol Metab.
95:E403–E412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chung BH, Kim JD, Kim CK, Kim JH, Won MH,
Lee HS, Dong MS, Ha KS, Kwon YG and Kim YM: Icariin stimulates
angiogenesis by activating the MEK/ERK-and PI3K/Akt/eNOS-dependent
signal pathways in human endothelial cells. Biochem Biophys Res
Commun. 376:404–408. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fekrat S, de Juan E Jr and Campochiaro PA:
The effect of oral 13-cis-retinoic acid on retinal redetachment
after surgical repair in eyes with proliferative vitreoretinopathy.
Ophthalmology. 102:412–418. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wiedemann P, Hilgers RD, Bauer P and
Heimann K: Adjunctive daunorubicin in the treatment of
proliferative vitreoretinopathy: Results of a multicenter clinical
trial. Daunomycin Study Group. Am J Ophthalmol. 126:550–559. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Asaria RH, Kon CH, Bunce C, Charteris DG,
Wong D, Khaw PT and Aylward GW: Adjuvant 5-fluorouracil and heparin
prevents proliferative vitreoretinopathy: Results from a
randomized, double-blind, controlled clinical trial. Ophthalmol.
108:1179–1183. 2001. View Article : Google Scholar
|
|
29
|
Chang YC, Kao YH, Hu DN, Tsai LY and Wu
WC: All-trans retinoic acid remodels extracellular matrix and
suppresses laminin-enhanced contractility of cultured human retinal
pigment epithelial cells. Exp Eye Res. 8:900–909. 2009. View Article : Google Scholar
|
|
30
|
Sadaka A and Giuliari GP: Proliferative
vitreoretinopathy: Current and emerging treatments. Clin
Ophthalmol. 6:1325–1333. 2012.PubMed/NCBI
|
|
31
|
Chang YC, Hu DN and Wu WC: Effect of oral
13-cis-retinoic acid treatment on postoperative clinical outcome of
eyes with proliferative vitreoretinopathy. Am J Ophthalmol.
146:440–446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kishimoto T: Interleukin-6: Discovery of a
pleiotropic cytokine. Arthritis Res Ther. 8 (Suppl 2):S22006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuppner MC, McKillop-Smith S and Forrester
JV: TGF-beta and IL-1 beta act in synergy to enhance IL-6 and IL-8
mRNA levels and IL-6 production by human retinal pigment epithelial
cells. Immunology. 84:265–271. 1995.PubMed/NCBI
|
|
34
|
Holtkamp GM, Van Rossem M, de Vos AF,
Willekens B, Peek R and Kijlstra A: Polarized secretion of IL-6 and
IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol.
112:34–43. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Romano M, Sironi M, Toniatti C,
Polentarutti N, Fruscella P, Faggioni R, Luini W, van Hinsbergh V,
Sozzani S, Bussolino F, et al: Role of IL-6 and its soluble
receptor in induction of chemokines and leukocyte recruitment.
Immunity. 6:315–325. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Deshmane SL, Kremlev S, Amini S and Sawaya
BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J
Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han QH, Hui YN, Du HJ, Zhang WJ, Ma JX and
Wang SY: Migration of retinal pigment epithelial cells in vitro
modulated by monocyte chemotactic protein-1: Enhancement and
inhibition. Graefes Arch Clin Exp Ophthalmol. 239:531–538. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mitamura Y, Takeuchi S, Yamamoto S,
Yamamoto T, Tsukahara I, Matsuda A, Tagawa Y, Mizue Y and Nishihira
J: Monocyte chemotactic protein-1 levels in the vitreous of
patients with proliferative vitreoretinopathy. Jpn J Ophthalmol.
46:218–221. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xie J, Yang L, Tian L, Li W, Yang L and Li
L: Macrophage migration inhibitor factor upregulates MCP-1
expression in an autocrine manner in hepatocytes during acute mouse
liver injury. Sci Rep. 6:276652016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Gu R, Jia J, Hou T, Zheng LT and
Zhen X: Inhibition of macrophage migration inhibitory factor (MIF)
tautomerase activity suppresses microglia-mediated inflammatory
responses. Clin Exp Pharmacol Physiol. 43:1134–1144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ko JA, Sotani Y, Ibrahim DG and Kiuchi Y:
Role of macrophage migration inhibitory factor (MIF) in the effects
of oxidative stress on human retinal pigment epithelial cells. Cell
Biochem Funct. 35:426–432. 2017. View
Article : Google Scholar : PubMed/NCBI
|
